Document Detail

Bleeding Complications With Regional Adaptation of a Prolonged Bivalirudin Regimen for ST-Elevation Acute Myocardial Infarction.
MedLine Citation:
PMID:  22901969     Owner:  NLM     Status:  Publisher    
Bivalirudin (BIV) is superior to a heparin/glycoprotein IIb/IIIa receptor inhibitor (GPI) strategy with respect to net adverse cardiovascular events for ST-segment elevation myocardial infarction (STEMI) percutaneous coronary intervention (PCI), albeit with an increased risk of acute stent thrombosis. We hypothesized that a 2-hour BIV infusion after PCI (BIV + 2) could be used without increased bleeding risk as a potential method of mitigating early thrombotic risk. We analyzed a 6-center regional protocol involving routine therapy with aspirin, clopidogrel, and bolus heparin followed by primary PCI for STEMI using BIV. All consecutive patients presenting with STEMI requiring primary PCI were included (2009 to 2011). We compared baseline characteristics and clinical outcomes of the University of Vermont Regional Registry to the historical groups of BIV (BIV terminated at end of PCI) or unfractionated heparin/GPI from the HORIZONS trial and determined independent predictors of bleeding. Of 346 patients undergoing PCI for STEMI, 98% received BIV; 82% of patients received BIV + 2, and 13.3% of all patients receiving BIV received GPI bailout. All-cause mortality was 3.1%. Overall bleeding rates were 50% less than in the HORIZONS GPI arm and similar to the HORIZONS BIV arm. Acute stent thrombosis occurred in <1.0% of patients. Bailout GPI was a potent independent predictor of bleeding complications. In conclusion, BIV + 2 is a feasible regional pharmacologic algorithm for STEMI PCI; BIV + 2 for STEMI PCI is not associated with increased bleeding risk and warrants further study as a mechanism of mitigating very early thrombosis risk.
Enkhtuyaa Mueller; William Prabhu; Michael Desarno; Preeth Sundaran; Harold Dauerman
Related Documents :
11811389 - Beta-blockade in hypertension and congestive heart failure.
10926109 - Cardiac complications of end-stage renal disease.
3038369 - Denervation supersensitivity of refractoriness in noninfarcted areas apical to transmur...
7722129 - Treatment with beta-adrenergic blocking agents after myocardial infarction: from random...
11688609 - Beta-blockers: a new therapy in congestive heart failure.
21749369 - Atrium electromechanical interval in left ventricular diastolic dysfunction.
1537999 - Long-term multicenter experience with a second-generation implantable pacemaker-defibri...
21763199 - Left atrial size-another differentiator for cardiac amyloidosis.
21731989 - Electrocardiography series. what is the cause of the regular wide qrs complex tachycardia?
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-14
Journal Detail:
Title:  The American journal of cardiology     Volume:  -     ISSN:  1879-1913     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Inc. All rights reserved.
University of Vermont, Burlington, Vermont.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Sexual hormones and erectile function more than 6 years after bariatric surgery.
Next Document:  Appropriateness of Statins in Patients Aged ?80 Years and Comparison to Other Age Groups.